Animal Model Market to Reach $2.67 Bn, Globally, by 2030 at 6.1% CAGR: Allied Market Research

Rise in usage of animal models in virology and infectious diseases and increase in adoption of CRISPR technology drive the growth of the global animal model market.

Rise in usage of animal models in virology and infectious diseases and increase in adoption of CRISPR technology drive the growth of the global animal model market.

Allied Market Research published a report, titled, “Animal Model Market by Animal Type (Rat, Mice, Guinea Pigs, Rabbits, and Others), Application (Drug Discovery & Development, Basic Research, and Others), and End User (Pharma & Biotech Companies, Academic Research Institutes, and Others): Global Opportunity Analysis and Industry Forecast, 2021–2030.” According to the report, the global Animal Model Market was estimated at $1.46 billion in 2020, and is anticipated to hit $2.67 billion by 2030, registering a CAGR of 6.1% from 2021 to 2030.

Download Sample Report at: https://www.alliedmarketresearch.com/request-sample/6464

Drivers, restraints, and opportunities-

Rise in usage of animal models in virology and infectious diseases, increase in adoption of CRISPR technology, and upsurge in likelihood of epidemic or pandemic outbreaks drive the growth of the global animal model market. On the other hand, regulations and laws for ethical use of animals in research restrain the growth to some extent. Nevertheless, several growth opportunities in the emerging markets have proved to be beneficial for the market.

Covid-19 scenario-

  • The outbreak of COVID-19 gave way to rise in demand for large number of animal models, due to increase in R&D activities related to antiviral drugs and vaccines.
  • This trend is anticipated to persist so as to verify the safety & efficacy of new entities before going for human trials.

The drug discovery and development segment to dominate by 2030-

By application, the drug discovery and development segment accounted for nearly three-fourths of the global animal model market share in 2020, and is expected to dominate by 2030. The same segment is also expected to register the fastest CAGR of 6.6% throughout the forecast period. This is due to increase in adoption of animal models in drug discovery & development along with production of novel products by pharmaceuticals & biotechnology companies and rise in preclinical activities and toxicity testing during drug development.

Enquiry for Short-term and Long-term Impacts of COVID-19 at: https://www.alliedmarketresearch.com/purchase-enquiry/6464

The pharma and biotech companies segment to maintain the dominant share-

By end user, the pharma and biotech companies segment contributed to around two-thirds of the global animal model market revenue in in 2020, and is projected to rule the roost by the end of 2030. The same segment would also grow at the fastest CAGR of 6.7% from 2021-2030. This is attributed to rise in number of preclinical activities, surge in number of pharmaceutical and biotechnology companies, technological advancements in animal models, and increase in usage of humanized mouse models for preclinical translational research.

North America garnered the major share in 2020-

By region, North America held the major share in 2020, garnering nearly two-fifths of the global animal model market, owing to increase in preclinical activities by pharmaceutical and biotech companies during drug development, rise in use of animal models by CROs, and surge in focus on personalized medicines in this region. The market across Asia-Pacific, on the other hand, would cite the fastest CAGR of 7.3% during the forecast period, due to increase in research on biomedical and regenerative medicines, rise in awareness related to animal models, and availability of trained medical professionals in this province.

Key players in the industry-

  • Envigo
  • Eurofins Scientific SE
  • GenOway S.A.
  • Hera BioLabs (Transposagen Biopharmaceuticals)
  • JSR Corporation (Crown Bioscience Inc.)
  • Ozgene Pty Ltd.
  • The Jackson Laboratory
  • PerkinElmer, Inc. (Horizon Discovery Group plc.)
  • Charles River Laboratories International, Inc,
  • Taconic Biosciences

We have also published few syndicated market studies in the similar area that might be of your interest. Below are the report title for your reference, considering Impact of Covid-19 Over This Market which will help you to assess aftereffects of pandemic on short-term and long-term growth trends of this market.

Similar Reports:

Animal Vaccines Market - Global Opportunity Analysis and Industry Forecast, 2020–2028

Animal Therapeutics and Diagnostics Market - Global Opportunity Analysis and Industry Forecast, 2019-2028

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
Follow Us on LinkedIn: https://www.linkedin.com/company/allied-market-research